Objectives: To determine the routine efficacy of a day case cardioversion system operating in a remote geographical area with an unselected case referral base and a proportion of direct GP access. Design: Prospective analysis of all admitted cases in a 13 week period. Participants: 47 consecutive patients admitted for 49 planned episodes of electrical cardioversion. Measurements: Pre procedural investigations and preparation, immediate and three-month outcome of rhythm following ECV Results: We found a predominant use by the cardiac unit despite working within a general medical service unit suggesting low case selection from non-cardiac sources. We suspected and confirmed a high rate of point of care treatment cancellation. Poor management of anticoagulation was the dominant reason for canceling planned treatment. Procedural preparation in terms of anti arrhythmic drug therapy and investigations seemed well preserved. Conclusion: New strategies for initiating and sustaining adequate outpatient warfarin therapy are needed to allow such systems to operate efficiently.
PelosiFMoradyF.Evaluation and management of atrial fibrillation. Med Clin N. America, 200185: 225–246.
2.
LipkinDPFrenneauxMStewartRJoshiJLoweTMcKennaWJ.Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinusrhythm. Br Heart J., 198859: 572–7.
3.
MayCDDavisMJ.The safety and economic advantages of day case electrophysiologic studies. Aust N Z J Med., 199222 (3): 240–2.
4.
SchwartzmanDMusleySKSwerdlowCHoytRHWarmanEN.Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol., 200240: 93–9.
5.
HamptonJRGrayA.The future of general medicine: lessons from a general admissions ward. J. Roy Coll. Phys. Lond.1998; 32: 39–43.
6.
LipGYHZarifisJWatsonRDSBeeversDG.Physician variation in the management of patients with atrial fibrillation. Heart1996; 75: 200–205.
7.
BerryCStewartSPayneEMMcArthurJDMcMurrayJJV.Electrical cardioversion for atrial fibrillation: outcomes in “real life” clinical practice. Int. J. Cardiol.81:29–35.
8.
Van GelderICHagensVEBoskerHAA comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New Eng J, Med.2002; 347: 1834–1840.
9.
LevyTWalkerSMasonMSpurrellPRexSBrantSPaulV.Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study. Heart2001; 85: 171–178.
10.
LumerGBTalajicM RoyCouturierAAmiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur. Heart J.2002; 23: 1050–1056.
11.
RaipancholiaRSentinellaLLynchM.Role of conscious sedation for external cardioversion. Heart2001; 86: 571–572.
12.
GoldnerBGBakerJAccordinoASagatinoLDiGiulioMKalenderianDLinDZambrottaVStechelJMaccaroPJadonathR.Electrical cardioversion of atrial fibrillation or flutter with conscious sedation in age of cost containment. Amer. Heart J.1998; 136: 961–964.
13.
StonehamMD.Anaesthesia for cardioversion. Anaes1996; 51: 565–570.
14.
GaleDWGrissomTEMirendaJV.Titration of intravenous anesthetics for cardioversion — Comparison of propofol; methohexital and midazolam. Crit. Care Med.1993; 21: 1509–1513.
15.
NishinoMHoshidaSTanouchiJItoTKatoJIwaiKTanahashiHHoriMYamadaYKamadaT.Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol., 200085: 1451–4.
16.
MattioliAVCastelliAAndriaAMattioliG.Clinical and echocardiographic features influencing recovery of atrial function after cardioversion of atrial fibrillation. Am J Cardiol., 199882: 1368–71.
17.
HylekEMSkatesSJSheehanMASingerDE.An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation. New Eng. J. Med.1996; 335: 540–6.
18.
MatcharDBSamsaGPCohenSJOddoneEZJurgelskiAE.Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: Results of the Managing Anticoagulation Services Trial. Am. J. Med., 2002, 113: 42–51.
19.
HirriHMGreenPJ.Audit of anticoagulant therapy and acute hospital admissions. Clin. Lab. Haematol.2002; 24: 43–45.
20.
LipGYHTeanKNDunnFG.Treatment of atrial fibrillation in a district general hospital. Br. Heart. J.1994; 71: 92–95.
21.
SchreiberTLElkhatibAGrinesCLO'NeillWW.Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J. Am. Coll. Cardiol.1995; 26: 577–582.
22.
CatherwoodEFitzpatrickWDGreenbergMLHolzbergerPTMalenkaDJGerlingBRBirkmeyerJD.Cost effectiveness of cardioversion and anti-arrhythmic therapy in non-valvular atrial fibrillation. Ann. Int. Med.1999; 130: 625–630.
23.
CapucciAVillaniGQAschieriDRosiAPiepoliMF.Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur. Heart J.2000; 21:66–73.
24.
FalkRHKnowltonAABernardSAGotliebNEBattinelli NJ Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med, 1987 Apr; 106 (4): 503–6.
